New data captures German prescribing insights providing
researchers with aggregated, anonymised specialty prescribing
habits across brands and diseases
LONDON, July 27, 2023 /PRNewswire/ -- Clarivate Plc
(NYSE: CLVT), a global leader in connecting people and
organizations to intelligence they can trust to transform their
world, today announced the release of German hospital prescribing
insights within Clarivate Patient Data Intelligence (CPDI). The
introduction of the new aggregated, anonymised data product will
allow for increased understanding of treatments prescribed and
administered in German hospitals, providing clarity on market
trends, patient characteristics, and specialty prescribing habits
across brands and diseases.
CPDI is the first supplier of this data product, reinforcing
Clarivate's position as a leading provider of real-world data
solutions in Europe. Sourced from
prescribing modules from hospital EHR software, showing treatments
prescribed and administered in the hospital setting, the insights
capture German in-patient and out-patient care, in an aggregated,
anonymised manner.
The addition of German hospital prescribing insights expands the
capabilities of CPDI to enable life sciences professionals to
examine the volumes of prescribed drugs by different physician
specialties. Pharma companies can identify specialties that are
most interested in their products compared to competitors' and they
can optimize commercial targeting.
Zoe Barker, Vice President of
Product, Clarivate, said: "Significant investment of resources
is required to analyze real world data products, particularly to
understand the European market landscape, patient behavior, and
prescribing habits. Such investment can delay the success of drug
launches. With the addition of German hospital prescribing
insights, Clarivate continues to deliver market leading
intelligence that empowers life science and healthcare
organizations to create a healthier tomorrow."
Patient Data Intelligence is a fast and intuitive self-service
platform that provides a detailed view, in an aggregated,
anonymised manner, of the dispensing and prescribing patterns and
patient behavior to help life sciences professionals make more
informed decisions in key European markets, including Italy, France, Spain
and Germany.
Our continuing investment in Clarivate Patient Data Intelligence
supports the industry's ever-growing need to engage patients,
physicians and payers in new ways, navigate barriers to access and
adherence, and address patient unmet needs. We will continue to
invest and explore innovative technologies, including artificial
intelligence and machine learning, that can support our customers'
efforts to solve healthcare's biggest challenges across the entire
drug, device and medical technology lifecycle.
To learn more about the Clarivate Patient Data Intelligence,
visit here.
About Clarivate
Clarivate™ is a leading global information services provider. We
connect people and organizations to intelligence they can trust to
transform their perspective, their work and our world. Our
subscription and technology-based solutions are coupled with deep
domain expertise and cover the areas of Academia & Government,
Life Sciences & Healthcare and Intellectual Property. For more
information, please visit www.clarivate.com .
Media contact:
Catherine
Daniel
Director External Communications, Life Sciences &
Healthcare
newsroom@clarivate.com
Logo -
https://mma.prnewswire.com/media/1159266/Clarivate_Logo.jpg
View original
content:https://www.prnewswire.co.uk/news-releases/clarivate-enhances-patient-data-intelligence-solution-with-addition-of-german-hospital-prescribing-insights-301886492.html